An immune drug developer raises $50M to finance its eczema drug testing
An immune drug developer raises $50M to finance its eczema drug testing
Body unavailable. Use the original source.
An immune drug developer raises $50M to finance its eczema drug testing
A compact weekly email covering company moves, product signals, regulatory updates, and notable funding.